Loading...
01/10 16:02
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call shows improvements in gross margin and reduced net loss, but revenue remains flat with ongoing financial risks. The Q&A reveals optimism for product expansion and margin improvement, yet competitive pressures and vague management responses pose uncertainties. The lack of a share repurchase program and the net loss per share are concerning. Considering these factors, the overall sentiment is neutral, with potential for slight positive movement if strategic initiatives succeed.
Total Revenue $4.2 million, relatively flat compared to Q2 2023; slight increase driven by core product portfolio, primarily cut herbs and vitamin supplements, offset by strategic shift away from lower-margin products.
Cost of Goods Sold $2.7 million, decreased by 37% compared to Q2 2023; decrease driven by the company's strategic shift away from third-party growers.
Gross Profit Increased by 157% compared to Q2 2023; driven by the shift away from dependence on third-party growers.
Gross Margin Increased to 34.4% in Q2 2024 from 13.1% in Q2 2023; improvement attributed to the strategic shift away from third-party growers.
Selling, General and Administrative Expenses $2.7 million, increased from $2.4 million in Q2 2023; increase primarily due to higher audit, accounting, and legal fees related to capital raising activities and a one-time expense of $100,000.
Net Loss per Share $1.21 per share for Q2 2024, compared to a net loss of $4.83 per share for Q2 2023; improvement in loss from operations by $645,000, but higher interest expense and a one-time loss on extinguishment of debt contributed to the increase in net loss.
Loss from Operations Improved by $645,000 from a loss of $1.83 million in Q2 2023 to $1.18 million in Q2 2024; improvement attributed to strategic shifts in product mix.
New Product Launches: Launched Garden Starters, potted herbs and basil bowls designed for home gardening, catering to the growing popularity of home gardening.
Product Development Partnership: Entered a partnership with Hermann Pickle Company to explore and develop scalable commercial opportunities in fermented plant-based products.
Market Expansion: Expanded distribution of pulp line of sustainable USDA organic fermented gourmet sauces with UNFI distributors, reaching over 30,000 locations.
Retail Distribution Growth: Added Seasons Kosher and Lincoln Market to the retail distribution network, enhancing product availability.
New Retail Partnerships: Strengthened distribution through Hemingway’s, serving over 350 retailers in the Northeast.
Operational Efficiency: Shifted focus to higher-margin businesses, resulting in a gross margin increase to 36.7% from 13.1% year-over-year.
Cost Reduction: Cost of goods sold decreased by 37% to $2.7 million, driven by the strategic shift away from third-party growers.
Strategic Shift: Conducted a thorough review of operations, moving away from less profitable segments to focus on higher-margin segments.
Sustainability Initiatives: Implemented new proprietary innovations in packaging and shipping to extend shelf life and reduce spoilage.
Competitive Pressures: The company is facing competitive pressures in the sauces and condiments market, which is projected to grow significantly, indicating a need for differentiation and innovation to maintain market share.
Regulatory Issues: The company must navigate regulatory requirements related to food safety and labeling, which can impact operational costs and product development timelines.
Supply Chain Challenges: The shift away from third-party growers may lead to supply chain challenges, including potential disruptions in sourcing raw materials and managing production in-house.
Economic Factors: Economic fluctuations could affect consumer spending on premium products, impacting sales and revenue growth.
Financial Risks: The company reported a net loss of $1.21 per share, indicating ongoing financial challenges that could affect future operations and investments.
Operational Risks: The transition to a more vertically integrated model poses operational risks, including the need for effective management of production, packaging, and distribution processes.
Gross Profit Increase: 157% increase in gross profit driven by 61% growth in cut herbs and 30% growth in vitamins and supplements.
Gross Margin Improvement: Gross margin increased to 36.7% in Q2 2024, up from 13.1% in Q2 2023.
Strategic Shift: The company is moving away from less profitable segments and focusing on higher-margin businesses.
Distribution Expansion: Expanded distribution of pulp line with UNFI, reaching over 30,000 locations.
Retail Partnerships: Strengthened distribution through partnerships with Hemingway’s and other retailers.
Product Development Partnership: Entered a partnership with Hermann Pickle Company to develop fermented plant-based products.
Sustainability Initiatives: Implemented new packaging innovations to extend shelf life and reduce spoilage.
Community Involvement: Launched a training program for individuals with disabilities, enhancing workforce diversity.
Revenue Expectations: Total revenue for Q2 2024 was $4.2 million, relatively flat compared to Q2 2023.
Cost of Goods Sold: Cost of goods sold decreased by 37% to $2.7 million in Q2 2024.
Net Loss: Net loss was $1.21 per share for Q2 2024, improved from $4.83 per share in Q2 2023.
Future Outlook: The company aims to become cash flow positive in the near future.
Share Repurchase Program: None
Despite revenue growth and strategic expansion plans, the company faces significant challenges: declining gross profit, increased operating expenses, and a widening net loss. The cash position has deteriorated, raising liquidity concerns. While there are positive strategic initiatives, such as the NaturalShrimp facility and retailer partnerships, the lack of detailed guidance and the negative financial metrics overshadow these efforts. The Q&A session highlighted management's vague responses, further contributing to uncertainty. Given these factors, the stock price is likely to experience a negative reaction in the short term.
The earnings call presents a mixed picture: while there are strategic realignments and positive developments like the NaturalShrimp acquisition and high-margin product focus, financials reflect declining revenue and increased losses. The Q&A reveals growth in private labels and optimism about new product lines, but management's vague responses on specifics raise concerns. The company's dependency on new revenue streams and margin pressures add uncertainty. Considering these factors, the stock price is likely to remain stable, hence a neutral sentiment.
The earnings call presents a mixed outlook: while there are improvements in gross margin and a focus on higher-margin products, revenue decline and competitive pressures remain concerns. The Q&A highlights potential growth in new product lines and strategic acquisitions, but lacks clarity on financial impacts. The absence of shareholder return plans and the risks associated with acquisitions and regulatory compliance temper optimism. Overall, the sentiment is balanced, suggesting a neutral stock price movement.
The earnings call reflects mixed signals. The strategic refocus on high-margin products and improved gross margin are positives, while the revenue decline and competitive pressures are negatives. The acquisition of Natural Shrimp poses risks, and the lack of a share repurchase plan is neutral. Q&A insights show optimism in sports nutrition but uncertainty in shrimp operations. The overall sentiment is neutral, with potential for growth balanced by current challenges and uncertainties.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
